Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects

被引:2
作者
Wu, Juan [1 ,2 ,3 ]
Xu, Hongrong [1 ,2 ]
Li, Hui [1 ,2 ]
Ma, Lei [4 ]
Chen, Juan [4 ]
Yuan, Fei [1 ,2 ]
Sheng, Lei [1 ,2 ]
Liu, Chao [1 ,2 ]
Chen, Weili [1 ,2 ]
Li, Xuening [1 ,2 ,5 ,6 ]
机构
[1] Fudan Univ, ZhongShan Hosp, Dept Clin Pharmacol, Shanghai, Peoples R China
[2] Fudan Univ, ZhongShan Hosp, Canc Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pharm, Shanghai, Peoples R China
[4] Haihe Biopharm Co Ltd, Shanghai, Peoples R China
[5] Fudan Univ, ZhongShan Hosp, Dept Clin Pharmacol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[6] Fudan Univ, ZhongShan Hosp, Canc Ctr, 180 Fenglin Rd, Shanghai 200032, Peoples R China
关键词
SCC244; c -Met inhibitor; food effect; pharmacokinetics; safety; CELL LUNG-CANCER; DRUG ABSORPTION; RESISTANCE; THERAPIES; AGENTS; FAT;
D O I
10.2147/DDDT.S388846
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: This study aimed to investigate the effect of food on the pharmacokinetics and safety profiles of SCC244, a novel oral c-Met inhibitor in healthy Chinese male subjects.Methods: It was a randomized, open-label, and 3-period crossover design, single-dose phase I clinical trial. A total of 18 healthy male subjects were enrolled. These subjects received a single oral 300 mg dose of SCC244 with a 14-day washout between each period. Blood samples were collected at the designated time points and determined using a validated liquid chromatography tandem mass spectrometry method. Pharmacokinetic parameters were calculated by noncompartmental methods. Tolerability was assessed by physical examination, vital sign measurements, 12-lead ECG, clinical laboratory tests, and adverse events (AEs) monitoring through-out the study.Results: Eighteen eligible subjects were enrolled in the study. The ratios (90% CI) of Cmax values for SCC244 in high-fat and low-fat meal states to that observed in fasted state were 194.8% (174.3-217.7%) and 194.6% (174.1-217.5%), respectively. The ratios of AUC0-t and AUC0-inf in the high-fat meal state versus the fasted state were 237.4% (208.7-270.0%) and 235.9% (207.5-268.3%), respectively. The ratios of AUC0-t and AUC0-inf in the low-fat meal state versus the fasted state were 219.2% (192.7-249.3%) and 218.3% (192.0-248.3%), respectively. Median Tmax values and mean t1/2 were similar in all groups. The most common AEs were headache, blood fibrinogen decreased, head discomfort, dizziness, and protein urine presence. All AEs were Common Terminology Criteria for Adverse Events (CTCAE) grade 1 (except 1 case of grade 2) and have resolved by the end of the study.Conclusion: The bioavailability of the tablet formulation of SCC244 was significantly increased when administered with high-and low-fat meals. However, the meals did not affect the median Tmax and t1/2. Safety under different fed conditions was comparable to fasted conditions in this study.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 26 条
[1]   Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models [J].
Ai, Jing ;
Chen, Yi ;
Peng, Xia ;
Ji, Yinchun ;
Xi, Yong ;
Shen, Yanyan ;
Yang, Xinying ;
Su, Yi ;
Sun, Yiming ;
Gao, Yinglei ;
Ma, Yuchi ;
Xiong, Bing ;
Shen, Jingkang ;
Ding, Jian ;
Geng, Meiyu .
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (04) :751-762
[2]   Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer [J].
Bardelli, Alberto ;
Corso, Simona ;
Bertotti, Andrea ;
Hobor, Sebastijan ;
Valtorta, Emanuele ;
Siravegna, Giulia ;
Sartore-Bianchi, Andrea ;
Scala, Elisa ;
Cassingena, Andrea ;
Zecchin, Davide ;
Apicella, Maria ;
Migliardi, Giorgia ;
Galimi, Francesco ;
Lauricella, Calogero ;
Zanon, Carlo ;
Perera, Timothy ;
Veronese, Silvio ;
Corti, Giorgio ;
Amatu, Alessio ;
Gambacorta, Marcello ;
Diaz, Luis A., Jr. ;
Sausen, Mark ;
Velculescu, Victor E. ;
Comoglio, Paolo ;
Trusolino, Livio ;
Di Nicolantonio, Federica ;
Giordano, Silvia ;
Siena, Salvatore .
CANCER DISCOVERY, 2013, 3 (06) :658-673
[3]   Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy? [J].
Budha, N. R. ;
Frymoyer, A. ;
Smelick, G. S. ;
Jin, J. Y. ;
Yago, M. R. ;
Dresser, M. J. ;
Holden, S. N. ;
Benet, L. Z. ;
Ware, J. A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) :203-213
[4]   Role of caloric content on gastric emptying in humans [J].
Calbet, JAL ;
MacLean, DA .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 498 (02) :553-559
[5]   Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH [J].
Charman, WN ;
Porter, CJH ;
Mithani, S ;
Dressman, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :269-282
[6]   Individualized dosing of tyrosine kinase inhibitors: are we there yet? [J].
de Wit, Djoeke ;
Guchelaar, Henk-Jan ;
den Hartigh, Jan ;
Gelderblom, Hans ;
van Erp, Nielka P. .
DRUG DISCOVERY TODAY, 2015, 20 (01) :18-36
[7]   Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours [J].
Devriese, Lot A. ;
Koch, Kevin M. ;
Mergui-Roelvink, Marja ;
Matthys, Gemma M. ;
Ma, Wen Wee ;
Robidoux, Andre ;
Stephenson, Joe J. ;
Chu, Quincy S. C. ;
Orford, Keith W. ;
Cartee, Leanne ;
Botbyl, Jeff ;
Arya, Nikita ;
Schellens, Jan H. M. .
INVESTIGATIONAL NEW DRUGS, 2014, 32 (03) :481-488
[8]  
Food and Drug Administration, GUID IND FOOD EFF BI
[9]   Gastric Water Emptying under Fed State Clinical Trial Conditions Is as Fast as under Fasted Conditions [J].
Grimm, Michael ;
Scholz, Elisabeth ;
Koziolek, Mirko ;
Kuehn, Jens-Peter ;
Weitschies, Werner .
MOLECULAR PHARMACEUTICS, 2017, 14 (12) :4262-4271
[10]   Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer - A systematic review and meta-analysis [J].
Huy Gia Vuong ;
An Thi Nhat Ho ;
Altibi, Ahmed M. A. ;
Nakazawa, Tadao ;
Katoh, Ryohei ;
Kondo, Tetsuo .
LUNG CANCER, 2018, 123 :76-82